Novo Nordisk A/s
(OTC) NONOF
Novo Nordisk A/s Financials at a Glance
Market Cap
$163.63B
Revenue (TTM)
$308.88B
Net Income (TTM)
$102.37B
EPS (TTM)
$3.47
P/E Ratio
10.60
Dividend
$1.73
Beta (Volatility)
0.52 (Low)
Dividend
$1.73
Beta (Volatility)
0.52 (Low)
Price
$36.50
Volume
2,412,356
Open
$34.56
Price
$36.50
Volume
2,412,356
Open
$34.56
Previous Close
$36.50
Daily Range
$34.56 - $37.65
52-Week Range
$34.56 - $82.50
Dividend
$1.73
Beta (Volatility)
0.52 (Low)
Price
$36.50
Volume
2,412,356
Open
$34.56
Previous Close
$36.50
Daily Range
$34.56 - $37.65
52-Week Range
$34.56 - $82.50
NONOF News
NONOF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Novo Nordisk A/s
Industry
Pharmaceuticals
Sector
Health CareEmployees
68,794
CEO
Maziar Mike Doustdar
Website
www.novonordisk.comHeadquarters
Bagsvaerd, 2880, DK
NONOF Financials
Key Financial Metrics (TTM)
Gross Margin
81%
Operating Margin
41%
Net Income Margin
33%
Return on Equity
61%
Return on Capital
39%
Return on Assets
19%
Earnings Yield
9.43%
Dividend Yield
0.05%
Payout Ratio
50.53%
Stock Overview
Market Cap
$163.63B
Shares Outstanding
4.44B
Volume
2.41M
Short Interest
0.00%
Avg. Volume
160.39K
Financials (TTM)
Gross Profit
$247.74B
Operating Income
$134.71B
EBITDA
$149.10B
Operating Cash Flow
$118.83B
Capital Expenditure
$60.00B
Free Cash Flow
$58.83B
Cash & ST Invst.
$26.90B
Total Debt
$137.88B
Novo Nordisk A/s Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$78.96B
-7.8%
Gross Profit
$64.00B
-11.9%
Gross Margin
81.04%
N/A
Market Cap
$163.63B
N/A
Market Cap/Employee
$2.11M
N/A
Employees
77,406
N/A
Net Income
$26.83B
-5.0%
EBITDA
$37.30B
-7.1%
Quarterly Fundamentals
Net Cash
$110.98B
-45.1%
Accounts Receivable
$75.53B
-13.6%
Inventory
$49.51B
+21.2%
Long Term Debt
$125.89B
+40.4%
Short Term Debt
$11.99B
-8.6%
Return on Assets
18.87%
N/A
Return on Invested Capital
39.01%
N/A
Free Cash Flow
$10.79B
-153.4%
Operating Cash Flow
$7.60B
-38.2%